SR SR Speciality HospitalUrology & Orthopedic Center Book Appointment

Urology • Prostate-Cancer Diagnosis

Prostate Biopsy

Medical term: Transperineal or Transrectal Ultrasound-Guided Prostate Needle Biopsy

A prostate biopsy removes multiple tiny tissue cores for microscopic examination. It is the test that can confirm whether prostate cancer is present and, when cancer is found, describe its grade and extent within the sampled tissue.

Modern biopsy planning usually incorporates prostate MRI. The needle may pass through cleaned perineal skin or through the rectal wall, while ultrasound provides live guidance. The route, anaesthesia and sampling strategy must be confirmed before preparation begins.

Discuss Prostate Biopsy Check urgent symptoms ↓

Serious infection or urinary blockage after biopsy needs urgent care

Seek Urgent Medical Care After Biopsy If

  • You develop fever, shaking chills, confusion, marked weakness or feel suddenly very unwell.
  • You cannot pass urine or the lower abdomen becomes painfully full.
  • Urine contains large clots, bleeding is heavy or persistent, or you become dizzy or faint.
  • Rectal bleeding continues or is more than minor spotting after a transrectal procedure.
  • Perineal swelling expands rapidly, severe pain worsens or scrotal skin becomes dark.
  • You develop breathlessness, chest pain, collapse or cold, clammy skin.

Infection can progress quickly after a prostate biopsy, especially after a transrectal route. Do not wait for the pathology appointment if any warning symptom develops.

What Is a Prostate Biopsy?

A spring-loaded biopsy needle removes slender cores from selected areas of the prostate. Each core is placed in a labelled specimen container and examined by a pathologist.

A biopsy is not the same as a PSA blood test, digital rectal examination, MRI or imaging-only transrectal ultrasound. Those tests estimate risk or show anatomy; only tissue microscopy can establish a pathological diagnosis.

A biopsy samples the prostate—it does not remove it

The operation takes tiny tissue cores from mapped regions. It cannot examine every microscopic part of the gland, which is why biopsy findings must remain concordant with PSA, examination and MRI.

Why May a Prostate Biopsy Be Recommended?

Suspicious prostate MRI

A PI-RADS or Likert lesion requires targeted tissue diagnosis when overall risk supports biopsy.

Raised or rising PSA

PSA level, trend, age, prostate volume and PSA density remain concerning after appropriate review.

Abnormal examination

A firm, nodular or asymmetric prostate raises suspicion even when MRI or PSA is not definitive.

Persistent concern after a negative biopsy

PSA, MRI or examination remains discordant with the earlier benign samples.

Active-surveillance reassessment

Selected patients with known low-risk cancer need repeat tissue assessment as part of a monitoring protocol.

Uncertain previous pathology

An atypical, insufficient or difficult specimen may need targeted repeat sampling or specialist review.

A raised PSA does not automatically mean cancer and does not automatically require immediate biopsy. Infection, benign enlargement, age, family history, PSA density, MRI and personal health all influence the decision.

Why Is MRI Usually Performed Before Biopsy?

  • MRI identifies and maps areas more likely to contain clinically significant cancer.
  • It helps determine whether biopsy is needed when combined with PSA density and clinical risk.
  • It guides targeted cores and can identify anterior or apical regions that require deliberate sampling.
  • It may reduce unnecessary biopsy and over-detection of low-risk disease in carefully selected patients.
  • It does not rule out every cancer; biopsy can still be appropriate when MRI is negative but clinical suspicion remains high.

Biopsy without MRI may still be appropriate when MRI is unavailable or unsuitable, disease appears clearly advanced, or the result would not change a treatment decision. The reason should be explicit.

Transperineal and Transrectal Biopsy Compared

FeatureTransperineal biopsyTransrectal biopsy
Needle routeThrough cleaned skin between the scrotum and anus.Through the rectal wall behind the prostate.
Ultrasound probeUsually placed in the rectum for imaging only; the needle does not pass through the rectum.Placed in the rectum and guides needles through the rectal wall.
Infection riskLower because the needle avoids rectal bacteria, although infection remains possible.Higher because the needle crosses the rectal wall; strict infection precautions are required.
Prostate accessGood access to anterior, apical and mapped sectors.Good access to many posterior regions but some anterior areas can be harder to sample.
AnaesthesiaLocal anaesthesia is increasingly used; spinal or general anaesthesia may be chosen.Commonly local anaesthesia; another anaesthetic may be selected.
Distinct after-effectsPerineal bruising and temporary urinary retention can occur.Rectal bleeding and infection are more prominent route-specific concerns.

Transperineal biopsy is preferred in many current pathways because of its lower infectious risk and broad gland access. Transrectal biopsy remains available in selected settings when its benefits and infection precautions are appropriate.

Targeted, Systematic and Perilesional Sampling

StrategyWhat is sampledWhy it may be used
MRI-targeted coresThe needle is directed into an MRI-visible lesion.Concentrates sampling on the area most suspicious for significant cancer.
Perilesional coresTissue immediately around an MRI target is sampled.Compensates for small alignment errors and captures disease extending beyond the visible centre.
Systematic coresMapped regions across the prostate are sampled even if MRI does not show a focus there.Can detect cancer outside or missed by the MRI target.
Template or saturation samplingA larger number of cores covers the gland through a structured grid.Used selectively for persistent suspicion, difficult anterior disease or prior negative sampling.

The number of cores is individualized according to prostate size, MRI lesions, prior biopsy, clinical risk and the diagnostic question. More cores are not automatically better because bleeding, urinary retention and over-detection also matter.

How Is an MRI Target Reached?

Cognitive targeting

The operator mentally matches the MRI location with real-time ultrasound anatomy.

MRI–ultrasound fusion

Software overlays or co-registers the earlier MRI with the live ultrasound image.

Direct in-bore MRI biopsy

The biopsy is performed within the MRI environment in selected specialist centres.

No targeting method eliminates operator, registration or movement error. The MRI image, ultrasound map, needle position, lesion size and pathology result all require quality control and clinical correlation.

What Must Be Reviewed Before Biopsy?

QuestionWhat is reviewedWhy it matters
Is biopsy justified?PSA trend, density, examination, MRI, age, family history, health and preferences.Balances cancer detection against avoidable biopsy and over-diagnosis.
Which route and sampling plan?Transperineal or transrectal route; targeted, perilesional, systematic or template cores.Preparation and risks differ substantially.
Is infection present?Urinary symptoms, recent fever, urine testing when indicated and prior resistant infection.Active infection may require reassessment before elective biopsy.
Is bleeding risk increased?Regular treatment affecting clotting, bleeding history and relevant medical conditions.Requires an individualized interruption and restart plan—never an unsupervised stop.
Is urinary retention likely?Prostate size, poor flow, residual urine, previous retention and planned core number.May change route, anaesthesia, observation or catheter planning.
Is the anaesthetic plan suitable?Local, spinal or general anaesthesia, ability to position, health and anxiety.Determines fasting, escort and recovery requirements.

What Preparation May Be Required?

  • Confirm whether the biopsy is transperineal or transrectal and whether it uses local, spinal or general anaesthesia.
  • Follow only the procedure team’s individualized fasting, bowel, skin and infection-prevention instructions.
  • Provide a complete list of regular treatment, allergies, previous infections and any earlier bleeding after procedures.
  • Do not stop treatment affecting clotting without a documented interruption and restart plan from the responsible clinician.
  • Bring the MRI report and images, PSA history, previous biopsy pathology and relevant urine or blood results.
  • Arrange an escort when sedation, spinal or general anaesthesia, local policy or personal circumstances require one.

Preparation cannot safely be copied from another patient or from an earlier biopsy. Route, local resistance patterns, allergies, anaesthesia and bleeding risk change the plan.

What Happens During Transperineal Prostate Biopsy?

StageWhat happensPurpose
Position and skin preparationThe legs are supported and the perineal skin is exposed and cleaned.Provides safe sterile access behind the scrotum.
AnaesthesiaThe agreed local, spinal or general anaesthetic is administered.Controls skin, deeper-tissue and prostate discomfort.
Ultrasound mappingA covered ultrasound probe is placed in the rectum to display prostate anatomy and volume.Guides the needle while avoiding the urethra and other structures.
Needle accessA freehand guide, access cannula or grid directs the biopsy needle through one or more small skin punctures.Provides controlled access to mapped prostate sectors.
Targeted and mapped coresPlanned MRI targets and other required regions are sampled.Obtains representative tissue for diagnosis and grading.
Labelling and observationCores are separated and labelled by target or location; bleeding and urination are assessed before discharge.Preserves anatomical information and identifies early complications.

What Happens During Transrectal Prostate Biopsy?

The patient commonly lies on the side. After rectal examination, a covered ultrasound probe shows the prostate. Local anaesthesia is usually placed around the prostate, and the biopsy needle passes through a guide and the rectal wall to obtain targeted and systematic cores.

Because the needle crosses the rectum, the infection-prevention plan is particularly important. The procedure may still be performed under another anaesthetic when required. Small rectal bleeding can occur afterward, but persistent or heavy bleeding requires urgent review.

What Should I Expect After Biopsy?

  • Blood in the urine is common for several days and may appear intermittently.
  • Blood in semen (haematospermia) can be dark brown or red and may remain visible for several weeks.
  • Minor rectal spotting can follow a transrectal biopsy.
  • Perineal bruising or tenderness can follow a transperineal biopsy.
  • Urinary frequency, burning, reduced flow or prostate discomfort may occur temporarily.
  • Temporary erection difficulty can occur because of bruising, discomfort or anxiety.
  • Activity, driving, work and sexual activity should follow the procedure team’s discharge plan and anaesthetic restrictions.

The team should confirm how results will be communicated, who will review them and whom to contact if warning symptoms develop.

Do not wait for routine follow-up

Contact the Treating Team Urgently If

  • Fever, rigors, confusion, severe weakness or rapidly worsening illness develops.
  • You cannot pass urine or develop a painfully full lower abdomen.
  • Large clots, heavy urinary bleeding or ongoing rectal bleeding occurs.
  • Perineal swelling, pain or bruising expands rapidly.
  • You feel faint, breathless, clammy or unable to keep fluids down.

Tell the assessing team that you recently underwent prostate biopsy and whether the route was transperineal or transrectal.

Possible Risks and Limitations

RiskWhat it meansPossible consequence
Urinary bleedingNeedle tracks bleed into the urinary tract.Usually settles, but clots can cause retention or require admission.
Blood in semenBiopsy-related blood enters seminal fluid.Can persist for weeks but usually resolves.
Infection or sepsisBacteria enter urine, prostate or bloodstream.May require urgent hospital treatment; risk is generally lower with the transperineal route.
Urinary retentionSwelling, bleeding or pre-existing obstruction prevents urination.A temporary urinary catheter may be required.
Rectal bleedingThe rectal wall bleeds after transrectal needle passage.Usually minor; persistent or heavy bleeding needs assessment.
Perineal bruising or haematomaBlood collects beneath the needle-entry skin.Can cause swelling and discomfort and rarely needs intervention.
Temporary sexual effectsDiscomfort, bleeding or anxiety affects erections or ejaculation.Usually improves as bruising settles.
Sampling errorThe needle misses a cancer or does not capture its highest grade.Ongoing suspicion may require MRI review or repeat biopsy.
Over-diagnosisA low-risk cancer unlikely to cause harm is detected.Can create anxiety and requires careful discussion of monitoring versus treatment.

What Does the Pathology Report Tell Us?

Report featureWhat it meansWhy it matters
Benign prostate tissueNo cancer is identified in the sampled cores.Reassuring only when compatible with PSA, MRI and examination.
InflammationAcute or chronic inflammatory change is present.May help explain PSA but does not automatically account for all clinical suspicion.
Atypical small acinar proliferationA small suspicious focus is insufficient for a definite cancer diagnosis.Often prompts pathology review, MRI correlation or repeat targeted sampling.
High-grade prostatic intraepithelial neoplasiaAbnormal cells remain within prostate ducts or glands.Interpretation depends on extent, other findings and modern MRI context.
AdenocarcinomaThe common form of prostate cancer is present.Grade, amount, location and imaging determine the next discussion.
Gleason patterns and scoreThe two dominant microscopic growth patterns are added.Reflects biological aggressiveness.
ISUP Grade GroupCancer is grouped from 1 to 5 using the Gleason patterns.Higher groups generally indicate more aggressive disease.
Core involvementThe number of positive cores and cancer length or percentage are reported.Helps estimate tumour burden alongside MRI and stage.
Cribriform or intraductal patternSpecific adverse architectural features are identified.Can materially influence risk assessment and treatment planning.
Perineural invasionCancer is seen around a nerve within a biopsy core.Does not by itself prove that cancer has spread outside the prostate.

Does a Negative Biopsy Rule Out Prostate Cancer?

No biopsy samples every cell. A negative result lowers the likelihood of sampled cancer but does not completely exclude a small, anterior, difficult-to-target or missed lesion.

The result is considered concordant when benign pathology makes sense alongside PSA density, MRI, examination and subsequent PSA behaviour. Persistent discordance may lead to MRI re-review, pathology review, continued PSA surveillance or repeat targeted and systematic biopsy.

“Benign” Must Fit the Whole Diagnostic Picture

A reassuring pathology report should not automatically cancel follow-up when a high-suspicion MRI lesion, rising PSA or abnormal examination remains unexplained.

What Happens After the Result?

ResultPossible next stepImportant qualification
Benign and concordantPSA and clinical monitoring.Timing depends on baseline risk and PSA trend.
Benign but discordantMRI or pathology review and possible repeat biopsy.The reason for persistent suspicion should be documented.
Atypical or insufficientSpecialist pathology review or repeat targeted sampling.It is not the same as confirmed cancer.
Low-risk cancerActive surveillance may be discussed.Age, health, MRI, grade and tumour volume all matter.
Clinically significant cancerStaging and multidisciplinary treatment discussion.Biopsy grade is one component of the complete stage and risk group.

What Does a Technically Successful Biopsy Mean?

Technical success means the intended targets and mapped regions were sampled, cores were adequate and correctly labelled, complications were controlled and specimens reached pathology safely.

It does not guarantee that cancer is present, absent or fully graded. Diagnostic success requires pathology quality and agreement between tissue, MRI, PSA and examination.

Common Biopsy and Pathology Terms

CoreA narrow cylinder of prostate tissue removed by the biopsy needle.
Targeted biopsySampling directed at an MRI-visible lesion.
Systematic biopsySampling predefined regions across the prostate.
Perilesional samplingCores taken around an MRI target.
PI-RADS / Likert scoreAn MRI suspicion category—not a tissue diagnosis.
Gleason scoreThe sum of two dominant cancer growth patterns.
ISUP Grade GroupA five-group system translating Gleason patterns into risk categories.
Clinically significant cancerCancer whose grade and extent are more likely to affect health or require treatment discussion.
ConcordanceAgreement between pathology, imaging and clinical risk.

Common Myths

Myth “A raised PSA proves cancer.”
Fact PSA estimates risk but can rise for several benign reasons; biopsy provides tissue diagnosis.
Myth “Every biopsy needle passes through the rectum.”
Fact Transperineal biopsy passes through cleaned skin while the rectal probe supplies imaging.
Myth “A negative biopsy guarantees there is no cancer.”
Fact Sampling error is possible, so pathology must agree with MRI, PSA and examination.
Myth “MRI replaces biopsy.”
Fact MRI maps risk and guides sampling but cannot provide microscopic grade.
Myth “More cores are always better.”
Fact Sampling is tailored to the diagnostic question, because more cores also affect bleeding, retention and over-detection.
Myth “Finding prostate cancer always means immediate treatment.”
Fact Some low-risk cancers are managed with structured active surveillance after careful assessment.

Frequently Asked Questions

Why do I need a biopsy if I already had an MRI?

MRI estimates the likelihood and location of significant cancer. Biopsy provides tissue to confirm the diagnosis and determine grade.

Is transperineal biopsy better than transrectal biopsy?

Transperineal biopsy has a lower infectious risk and good anterior access, so it is preferred in many pathways. Route selection still depends on anatomy, resources, anaesthesia and the diagnostic plan.

Does the ultrasound probe take the biopsy?

No. The probe displays the prostate in real time; a separate needle takes the tissue cores.

Will I be awake?

Many transperineal and transrectal biopsies use local anaesthesia. Spinal or general anaesthesia may be selected according to the sampling plan and patient factors.

How many cores will be taken?

There is no single correct number. MRI targets, prostate size, systematic regions, previous biopsy and clinical risk determine the plan.

What is MRI-fusion biopsy?

Software aligns the earlier prostate MRI with live ultrasound so the operator can target the mapped lesion during needle sampling.

Why are systematic cores needed if there is an MRI target?

They can detect significant cancer outside the visible target or compensate for MRI and targeting limitations.

Is blood in urine normal?

A small amount is common for several days. Heavy bleeding, large clots, dizziness or inability to urinate needs urgent review.

How long can blood remain in semen?

Discolouration can remain visible for several weeks and may change from red to brown as it resolves.

Can biopsy cause infection?

Yes. The risk is lower with transperineal sampling but is not zero. Fever, shaking chills or sudden illness requires urgent assessment.

Can biopsy cause urinary retention?

Temporary swelling, bleeding and pre-existing obstruction can prevent urination, particularly after extensive sampling or in a large prostate.

Can biopsy spread prostate cancer?

Modern prostate needle biopsy is an established diagnostic procedure and is not considered to cause clinically meaningful cancer spread.

What does ISUP Grade Group 1 to 5 mean?

It summarizes Gleason growth patterns. Group 1 is the lowest grade and Group 5 the highest, but treatment decisions also use stage, PSA, MRI, tumour volume and health.

What if the biopsy is benign but PSA keeps rising?

The team may reassess PSA density, review MRI and pathology, monitor closely or recommend repeat targeted and systematic sampling.

When is higher-centre referral appropriate?

Complex MRI targeting, repeated negative biopsies with persistent high suspicion, unusual pathology, major bleeding or infection risk, or need for in-bore or specialist template sampling may warrant referral.

Related Patient Guides

PSA, MRI, ultrasound and biopsy answer different questions within the prostate-cancer diagnostic pathway.

ConditionProstate CancerDiagnosis, Risk and Treatment PathwaysRead condition guide → RadiologyTransrectal Prostate UltrasoundTRUS Imaging and Volume AssessmentRead scan guide → ConditionEnlarged ProstateBPH and Urinary ObstructionRead condition guide →

A Note From Our Doctors

The information on this page is intended to help you understand your condition. It should not be considered a diagnosis or a substitute for a consultation with a qualified medical professional.

Every patient is unique. The same symptom can have different causes in different individuals, and the most appropriate investigations and treatment depend on your medical history, examination findings, age, existing medical conditions and test results.

At SR Speciality Hospital, we believe in treating the whole patient—not just a symptom, scan or laboratory report. Every treatment plan is individualised after careful medical evaluation.

Urology Consultation

Has a prostate biopsy been recommended?

Arrange a consultation to review PSA, examination and MRI findings, confirm whether biopsy is necessary and choose an appropriate route and sampling plan.

Call the Hospital Contact Us